# Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue
Canonical URL: https://biopharmsignal.com/news/TMCI/treace-announces-preliminary-unaudited-fourth-quarter-and-full-year-2025-revenue
Ticker: TMCI
Company: Treace Medical Concepts
Source: Treace Medical Concepts
Published: 2026-01-13 12:05 EST
Original Source URL: https://investors.treace.com
## Summary

PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced its preliminary, unaudited

## Article Body
PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced its preliminary, unaudited
## Recent Company News
- 2026-05-08 11:05 EST — [Treace Medical Concepts Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TMCI/treace-medical-concepts-reports-first-quarter-2026-financial-results) — Source: Treace Medical Concepts
- 2026-04-24 11:05 EST — [Treace to Report First Quarter 2026 Financial Results on May 8, 2026](https://biopharmsignal.com/news/TMCI/treace-to-report-first-quarter-2026-financial-results-on-may-8-2026) — Source: Treace Medical Concepts
- 2026-04-07 13:04 EST — [Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System](https://biopharmsignal.com/news/TMCI/treace-announces-first-surgical-cases-with-the-superbitetm-compression-screw-system) — Source: Treace Medical Concepts
- 2026-02-27 12:05 EST — [Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results](https://biopharmsignal.com/news/TMCI/treace-medical-concepts-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: Treace Medical Concepts
- 2026-02-24 12:05 EST — [Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference](https://biopharmsignal.com/news/TMCI/treace-highlights-new-product-innovations-and-updated-positive-clinical-study-data-at-the-2026-acfas-annual-scientific-conference) — Source: Treace Medical Concepts
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)